Showing results (201-210 of 296) with videos related to
Sort By:
Pageof 30
Cancer Genetics and Cytogenetics|October 1, 1987
DNA aneuploidy in adult acute leukemiaB Barlogie, S Stass, D Dixon, et al.Blood Cells|January 1, 1983
Quantitative cytology in leukemia researchB Barlogie, A M Maddox, D A Johnston, et al.Leukemia|June 19, 2012
Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured?S Z Usmani, J Crowley, A Hoering, et al.Cancer Genetics and Cytogenetics|May 1, 1982
Prognostic implications of ploidy and proliferative activity in human solid tumorsB Barlogie, D A Johnston, L Smallwood, et al.Blood|November 26, 1999
Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemiaA Aguayo, E Estey, H Kantarjian, et al.British Journal of Haematology|September 13, 2001
Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 yearsA Badros, B Barlogie, E Siegel, et al.The Journal of Clinical Investigation|July 1, 1985
Pretreatment of cytokinetics in acute myelogenous leukemia. Age-related prognostic implicationsH M Kantarjian, B Barlogie, M J Keating, et al.Bone Marrow Transplantation|March 15, 2006
Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patientsM H Miceli, L Dong, M L Grazziutti, et al.Blood|August 15, 2000
High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISHJ Shaughnessy, E Tian, J Sawyer, et al.Blood|January 15, 1996
Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factorY Gazitt, E Tian, B Barlogie, et al.Pageof 30